Patent Assignment
Reel/Frame 024445/0267
Release of Security Interest in Patents
Recorded: 2010-05-27
Pages: 8
Assignor
CIT HEALTHCARE LLC
Executed: 2010-05-26
Assignee
ATON PHARMA, INC.
3150 BRUNSWICK PIKE, SUITE 230, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Properties
(5)
Ophthalmic Package and Delivery Device
Patent:
5,624,057 →
Application:
08/432,500 →
Piercing Container Cap
Patent:
5,758,788 →
Application:
08/729,974 →
Welding Process
Patent:
6,009,691 →
Application:
09/030,417 →
Uses of Trientine and Penicillamine as Countermeasures to Metal Contamination
Application:
12/180,130 →
Publication:
US 2009/0030079
Combined Dispenser and Cap
Patent:
405,005 →
Application:
29/080,877 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 13, 1996
From: LIFSHEY, ARTHUR L.
To: MERCK & CO., INC.
Reel/Frame 008216/0834 →
Assignment of Assignor's Interest
Mar 16, 1998
From: LIFSHEY, ARTHUR L.
To: MERCK & CO., INC.
Reel/Frame 009043/0632 →
Assignment of Assignor's Interest
Sep 21, 1998
From: LIFSHEY, ARTHUR L.
To: MERCK & CO., INC.
Reel/Frame 009460/0906 →
Assignment of Assignor's Interest
Oct 28, 1999
From: LIFSHEY, ARTHUR L.
To: MERCK & CO., INC.
Reel/Frame 010341/0464 →
Security Agreement
Feb 19, 2009
From: ATON PHARMA, INC.
To: CIT HEALTHCARE LLC, AS AGENT
Reel/Frame 022283/0515 →
Security Interest in Patent Licenses Between Merck & Co., Inc. and Aton Pharma, Inc.
Feb 19, 2009
From: ATON PHARMA, INC.
To: CIT HEALTHCARE LLC, AS AGENT
Reel/Frame 022277/0636 →
Assignment of Assignor's Interest
May 4, 2009
From: LEVINSON, BARRY; WELLS, MICHAEL
To: ATON PHARMA
Reel/Frame 022632/0743 →
Change of Name
Jan 27, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023854/0563 →
Change of Name
Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0293 →
Change of Name
Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →